Integrated Diagnostics Holdings PLC Notice of Results (6298W)
20 August 2020 - 2:16AM
UK Regulatory
TIDMIDHC
RNS Number : 6298W
Integrated Diagnostics Holdings PLC
19 August 2020
Integrated Diagnostics Holdings Plc Notice of results
19 August 2020
(London) - Integrated Diagnostics Holdings ("IDH," "the Group,"
or "the Company"), IDHC on the London Stock Exchange, a leading
consumer healthcare company with operations in Egypt, Jordan, Sudan
and Nigeria, will publish its unaudited results for the first half
ended 30 June 2020 on Wednesday, 2 September 2020 at 7am (UK).
An analyst and investor call will be hosted at 2pm (UK) | 3pm
(Egypt) on Wednesday, 2 September 2020. A live audio webcast can be
accessed at this link and you may dial in using the conference call
details below:
-- Access code: 257185
-- UK dial in: (Toll free) 0800 640 6441 / (Int'l) +44 20 3936 2999
-- USA dial in: (Toll free) +1 855 9796 654 / (Int'l) +1 646 664 1960
-- UAE dial in: (Toll free) 800 0357 04553
Contact
IDH
Nancy Fahmy +20 (0)12 2255 7445
Investor Relations Director nancy.fahmy@idhcorp.com
About Integrated Diagnostics Holdings
IDH is a leading consumer healthcare company in the Middle East
and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The
Group's core brands include Al Borg, Al Borg Scan and Al Mokhtabar
in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar
Sudan (both in Sudan) and Echo-Scan (Nigeria). A long track record
for quality and safety has earned the Company a trusted reputation,
as well as internationally recognised accreditations for its
portfolio of over 1,400 diagnostics tests. From its base of 462
branches as of 30 June 2020, IDH will continue to add laboratories
through a Hub, Spoke and Spike business model that provides a
scalable platform for efficient expansion. Beyond organic growth,
the Group's expansion plans include acquisitions in new Middle
Eastern and African markets where its model is well-suited to
capitalise on similar healthcare and consumer trends and capture a
significant share of fragmented markets. IDH has been a
Jersey-registered entity with a Standard Listing on the Main Market
of the London Stock Exchange (ticker: IDHC) since May 2015.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORMZGMRVLKGGZM
(END) Dow Jones Newswires
August 19, 2020 12:16 ET (16:16 GMT)
Integrated Diagnostics (LSE:IDHC)
Historical Stock Chart
From Apr 2024 to May 2024
Integrated Diagnostics (LSE:IDHC)
Historical Stock Chart
From May 2023 to May 2024